Peter A Kavsak Selected Research

Troponin

1/2022	High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality.
1/2022	High-sensitivity cardiac troponin and the importance of cutoffs in patients with prior coronary artery bypass grafting with suspected NSTEMI.
11/2021	Single troponin to rule-out MI in early presenters, perhaps, but not major adverse cardiac events.
9/2021	Can the Addition of NT-proBNP and Glucose Measurements Improve the Prognostication of High-Sensitivity Cardiac Troponin Measurements for Patients with Suspected Acute Coronary Syndrome?
8/2021	Diagnostic Performance of Serial High-Sensitivity Cardiac Troponin Measurements in the Emergency Setting.
3/2021	Acute Phase Response and Non-Reproducible Elevated Concentrations with a High-Sensitivity Cardiac Troponin I Assay.
1/2021	Admission High-Sensitivity Cardiac Troponin vs a Biochemical Score for Predicting Mortality in Patients With COVID-19.
1/2021	Combination of lymphocyte count and not the serological response with high-sensitivity cardiac troponin for risk stratification in patients with possible COVID-19.
1/2021	Independent and combined effects of biotin and hemolysis on high-sensitivity cardiac troponin assays.
1/2021	Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter A Kavsak Research Topics

Disease

39	Myocardial Infarction 01/2022 - 05/2006
27	Acute Coronary Syndrome 12/2021 - 03/2007
14	Chest Pain (Chest Pains) 01/2020 - 03/2007
7	Heart Failure 12/2021 - 03/2007
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 01/2013
4	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 09/2015
4	Pain (Aches) 09/2021 - 12/2007
4	COVID-19 08/2021 - 01/2021
4	Ischemia 01/2020 - 07/2006
3	Hemolysis 01/2021 - 01/2018
3	Hemorrhage 01/2021 - 08/2017
3	Heart Diseases (Heart Disease) 01/2020 - 09/2010
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2022 - 01/2019
2	Acute-Phase Reaction 03/2021 - 03/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2020 - 11/2015
2	Neoplasms (Cancer) 08/2019 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2016
2	Inflammation (Inflammations) 08/2017 - 01/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 05/2008
2	Necrosis 04/2008 - 01/2008
1	Non-ST Elevated Myocardial Infarction 01/2022
1	Cardiac Arrhythmias (Arrythmia) 09/2021
1	Convalescence 01/2021
1	Venous Thromboembolism 01/2021
1	Unstable Angina 10/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Chronic Disease (Chronic Diseases) 08/2018
1	Jaundice (Icterus) 01/2018
1	Fibrosis (Cirrhosis) 12/2017
1	Death (Near-Death Experience) 11/2017
1	Reperfusion Injury 08/2017
1	Dyspnea (Shortness of Breath) 01/2015
1	Neoplasm Metastasis (Metastasis) 07/2009
1	Cardiotoxicity 04/2008
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 06/2006

Drug/Important Bio-Agent (IBA)

48	TroponinIBA 01/2022 - 07/2006
23	trans-crotonin (CTN)IBA 06/2022 - 04/2008
19	Troponin IIBA 03/2021 - 07/2006
17	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2006
6	pro-brain natriuretic peptide (1-76)IBA 09/2021 - 12/2007
6	Troponin T (Troponin T1)IBA 01/2020 - 03/2011
5	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2017
5	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2019 - 12/2007
5	Interleukin-6 (Interleukin 6)IBA 09/2015 - 12/2007
4	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2017
4	CytokinesIBA 01/2016 - 12/2007
3	Natriuretic PeptidesIBA 09/2021 - 01/2019
2	Fatty Acid-Binding ProteinsIBA 12/2021 - 12/2018
2	Biotin (Vitamin H)FDA Link 01/2021 - 01/2019
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2013
2	Edetic Acid (EDTA)FDA Link 01/2018 - 03/2010
2	CDAA (Randox)IBA 01/2016 - 05/2008
2	Interleukin-10 (Interleukin 10)IBA 09/2015 - 03/2010
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2012 - 07/2006
2	C-Reactive ProteinIBA 08/2011 - 03/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2010 - 05/2008
2	Epidermal Growth Factor (EGF)IBA 03/2010 - 05/2008
2	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 10/2009 - 07/2009
2	Interleukin-8 (Interleukin 8)IBA 05/2008 - 12/2007
1	Fatty Acid Binding Protein 3IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 10/2020
1	VitaminsIBA 01/2019
1	Alkaline PhosphataseIBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	Galectin 3 (LGALS3)IBA 12/2017
1	CC ChemokinesIBA 08/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2017
1	LigandsIBA 08/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2017
1	Cell Adhesion MoleculesIBA 01/2016
1	ischemia-modified albuminIBA 01/2012
1	IsoenzymesIBA 01/2012
1	Protein Sorting Signals (Signal Peptide)IBA 02/2011
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2008
1	Sunitinib (Sutent)FDA Link 04/2008
1	Protein Isoforms (Isoforms)IBA 05/2007
1	MyoglobinIBA 05/2007

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2013
2	Blood Transfusion (Blood Transfusions) 01/2021 - 01/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022
1	Ambulatory Care (Outpatient Care) 08/2021
1	Long-Term Care 01/2021
1	Medication Errors (Medication Error) 01/2019